NCT01277419 German Spondyloarthritis Inception Cohort
| NCT ID | NCT01277419 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2000-07 |
| Primary Completion | 2030-07 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.
Eligibility Criteria
Main inclusion Criteria: * Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis. * Patients with definite diagnosis of Crohn's disease. * Patients with definite diagnosis of acute anterior uveitis. * Patients with definite diagnosis of psoriatic arthritis with axial involvement.